Filing Details

Accession Number:
0000059478-18-000123
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-17 15:29:45
Reporting Period:
2018-04-13
Accepted Time:
2018-04-17 15:29:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1463321 Susan Mahony Lilly Corporate Center
Indianapolis IN 46285
Svp & Pres., Lilly Oncology No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-13 5,165 $80.14 45,652 No 4 S Direct
Common Stock Disposition 2018-04-16 17,379 $80.08 28,273 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,738 Indirect 401(k)
Common Stock 1,727 Indirect 401(k) - by husband
Common Stock 14,874 Indirect by husband
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2018.
  2. This transaction was executed in multiple trades at prices ranging from $80.00 to $80.41. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $80.00 to $80.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. Reporting person disclaims beneficial ownership of these shares.